Ilmn stock forecast.

Jan 17, 2023 · Illumina stock (NASDAQ: ILMN) saw a significant 53% fall in the last twelve months, underperforming the broader S&P500 index, down 16%. Even in the longer term, ILMN stock is down 38% from levels ...

Ilmn stock forecast. Things To Know About Ilmn stock forecast.

136.31 0.00 0.00% The 19 analysts offering 1 year price forecasts for ILMN have a max estimate of — and a min estimate of —. Analyst rating Based on 21 analysts giving stock …Illumina (ILMN) Down 14.2% Since Last Earnings Report: Can It Rebound? (Zacks) Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research ...In after-hours trading on the stock market today, ILMN stock rose a fraction. During the regular session, shares surged 17% to close at 226.94. During the regular session, shares surged 17% to ...As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.For ILLUMINA INC stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average ILLUMINA INC stock forecast of $117.71, a high forecast of $140.93, and a low forecast of $87.66. The average ILLUMINA INC stock forecast 2028 represents a 17.51% increase from the last price of $100.169998168945.

Illumina stock (NASDAQ: ILMN) saw a significant 53% fall in the last twelve months, underperforming the broader S&P500 index, down 16%. Even in the longer term, ILMN stock is down 38% from levels ...Earnings Trend: ILMN is unprofitable, and losses have increased over the past 5 years at a rate of 64.3% per year. Accelerating Growth: Unable to compare ILMN's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: ILMN is unprofitable, making it difficult to compare its past year ...About the Illumina, Inc. stock forecast. As of 2023 November 29, Wednesday current price of ILMN stock is 94.680$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Illumina stock price has been showing a declining tendency so we believe that similar market segments …

View Illumina, Inc ILMN investment & stock information. Get the latest Illumina, Inc ILMN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Real time Illumina (ILMN) stock price quote, stock graph, news & analysis.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...May 5, 2022 · But Illumina stock is under pressure after falling below its 50-day line last month. For the year, Illumina guided to 14%-16% sales growth and adjusted earnings of $4-$4.20 per share. Nov 6, 2023 · November 6, 2023 at 10:41 AM · 3 min read. Wall Street analysts forecast that Illumina (ILMN) will report quarterly earnings of $0.13 per share in its upcoming release, pointing to a year-over ...

Illumina has risen higher in 14 of those 23 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.87%. Is Illumina Stock Undervalued? The current Illumina [ ILMN] share price is $101.57. The Score for ILMN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.

Their NVDA share price targets range from $195.00 to $780.00. On average, they predict the company's stock price to reach $588.38 in the next year. This suggests a possible upside of 25.8% from the stock's current price. View analysts price targets for NVDA or view top-rated stocks among Wall Street analysts.

It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Moderna, Inc.'s (NASDAQ:MRNA) Intrinsic Value Is Potentially 92% Above Its Share Price. Moderna Inc. stock outperforms market on strong trading day. Moderna reins in 2023 COVID vaccine forecast ...Aug 9, 2023 · adjusted earnings of 75 cents to 90 cents a share, down from the previously forecast range of $1.25 to $1.50 a share. Analysts are expecting $1.38. Illumina cut its sales growth forecast to 1% ... Illumina, a leading company specializing in DNA sequencing and array-based technologies, has recently announced the appointment of Jacob Thaysen asWeather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...View the latest Illumina Inc. (ILMN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Illumina Shares Drop on Forecast for 2023 Sales Decline ... Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time MRNA - Moderna Inc stock quotes, company profile, news and forecasts from CNN Business.ILMN stock forecast Statistics of Tudal See New Opinions/Signals for ALL Tickers Statistics from all past Buy/Sell opinions in Tudal Total return : 2366.52 % …Illumina Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction. ... ILMN Related stocks. Symbol 3M %Chg ; ILMN -38.84% : Illumina Inc: AMGN +7.18% ...0.53 0.54% After Hours Volume: 13.6K Advanced Charting Volume: 1.86M 65 Day Avg: 2.18M 85% vs Avg 96.22 Day Range 98.82 89.00 52 Week Range 238.55 Partner …

For ILLUMINA INC stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average ILLUMINA INC stock forecast of $117.71, a high forecast of $140.93, and a low forecast of $87.66. The average ILLUMINA INC stock forecast 2028 represents a 17.51% increase from the last price of $100.169998168945.

Revenue vs Market: ILMN's revenue (7.6% per year) is forecast to grow slower than the US market (8.1% per year).Aug 10, 2023 · ILMN stock briefly retook its 50-day line. ... Though earnings fell 44% year over year, they beat predictions for just a 2-cent gain per share. Illumina also shipped 109 NovaSeq X systems. Given ... A high-level overview of Illumina, Inc. (ILMN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Price Prediction forecast forIllumina to October 26, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts ILMN for 2023 with target levels, support & resistance insights to make informed investment decisions.Dec 3, 2023 · https://www.illumina.com. Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells ... Illumina (NASDAQ:ILMN) is a biotech company that develops and sells life science tools and integrated systems for genomic research. The stock has a consensus rating of Hold and a price target of $217.47, up 99.1% from its current price of …On the news, ILMN stock tumbled 8.6% to 270.13 on the stock market today. Earlier, Illumina shares dove as much as 11.9% to a five-month low of 260.42. Earlier, Illumina shares dove as much as 11. ...Nov 24, 2023 · Based on short-term price targets offered by 16 analysts, the average price target for Illumina comes to $199.44. The forecasts range from a low of $100.00 to a high of $334.00. The average price ...

Stock Price Forecast. The 19 analysts offering 12-month price forecasts for Illumina Inc have a median target of 125.00, with a high estimate of 260.00 and a low estimate of 50.00. The median estimate represents a +27.85% increase from the last price of 97.77.

May 5, 2022 · But Illumina stock is under pressure after falling below its 50-day line last month. For the year, Illumina guided to 14%-16% sales growth and adjusted earnings of $4-$4.20 per share.

According to 8 analyst offering 12-month price targets in the last 3 months, Illumina has an average price target of $230.0 with a high of $300.00 and a low of $150.00. Below is a summary of how ...Detailed statistics for Illumina, Inc. (ILMN) stock, including valuation metrics, financial numbers, share information and more. ... Stock Forecasts. Stock Splits ...Simply Wall St. July 22, 2023 at 7:00 AM · 3 min read. Today we're going to take a look at the well-established Illumina, Inc. ( NASDAQ:ILMN ). The company's stock received a lot of attention ...Stock Return Forecast - ILMN vs. TMO Trefis While ILMN stock may outperform TMO, the Covid-19 crisis has created many pricing discontinuities, which can offer attractive trading opportunities.ILMN stock forecast Statistics of Tudal See New Opinions/Signals for ALL Tickers Statistics from all past Buy/Sell opinions in Tudal Total return : 2366.52 % …Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Jul 7, 2023 · In contrast, here’s how ILMN stock and the broader market performed during the 2007/2008 crisis. Timeline of 2007-08 Crisis. 10/1/2007: Approximate pre-crisis peak in S&P 500 index Better trading starts here. Based on short-term price targets offered by 16 analysts, the average price target for Illumina comes to $140.06. The forecasts range …15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price.

The Bottom Line on ILMN Stock. Trading at a forward price-earnings ratio of 87.7, Illumina does have a high valuation. Still, given the company’s past growth and its tremendous future ...Their INTC share price targets range from $17.00 to $56.00. On average, they expect the company's stock price to reach $35.68 in the next twelve months. This suggests that the stock has a possible downside of 20.1%. View analysts price targets for INTC or view top-rated stocks among Wall Street analysts.The average 12-month stock price forecast for Illumina stock is $212.81, which predicts an increase of 94.49%. The lowest target is $100 and the highest is $334. On average, analysts rate Illumina stock as a hold. See the latest forecasts, ratings, financials, and EPS numbers for this biotechnology company.Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.Instagram:https://instagram. what quarters to look forstock predicttucker york goldman sachswhat does 150 odds mean ILMN stock analysts forecast earnings of $1.37 per share and $4.94 billion in sales this year. On the stock market today, ILMN stock tumbled 3.5% to end the regular session at 210.96. health insurance companies in atlanta gawhat does aaa renters insurance cover Premarkets Dow After-Hours Market Movers Fear & Greed World Markets Investing Markets Now Before the Bell Leading Indicator Global Energy Challenge Economy Energy Tech Innovate Gadget Mission:... best platform to trade oil There are also red-hot healthcare stocks like Illumina (NASDAQ: ILMN), a harbinger of the DNA revolution in healthcare. While the other companies on this list are treating diseases, Illumina is a ...17 ສ.ຫ. 2023 ... Illumina's second-quarter results touch off a 9% drop in the stock price, as well as 12-month price-target cuts by eight analysts.